Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Apnea, Obstructive 5Lung Neoplasms 5Sleep Apnea Syndromes 3Polycystic Ovary Syndrome 3Neoplasms 2Urogenital Neoplasms 1Unilateral Breast Neoplasms 1Thrombocythemia, Essential 1Small Cell Lung Carcinoma 1Polycythemia Vera 1Obesity 1Microcephaly, Primary Autosomal Recessive, 6 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Metformin 7Testosterone 2Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2Blood Pressure 2semaglutide 1maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Walking 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Topiramate 1Tirzepatide 1Sugars 1Spironolactone 1Qsymia 1Pyruvic Acid 1Pulse Wave Analysis 1Preoperative Exercise 1Pioglitazone 1Phlebotomy 1Phentermine 1Pancreaticoduodenectomy 1Orchiectomy 1Naltrexone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolic Syndrome × Continuous Positive Airway Pressure × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡